If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Director/PDMR Shareholding

9 Jul 2024 16:22

RNS Number : 7412V
De La Rue PLC
09 July 2024
 

De La Rue plc

 

Director/PDMR Shareholding

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

9 July 2024

De La Rue plc (the "Company") announces that on 8 July 2024 awards made under the De La Rue Deferred Bonus Plan (the "DBP") to Clive Vacher and Ruth Euling (each of whom is an Executive Director and a Person Discharging Managerial Responsibilities ("PDMR") of the Company) automatically vested and were released.

In line with the rules of the DBP, the Company withheld a proportion of each award and sold sufficient Shares to fund income tax and national insurance withholdings and the associated dealing costs. These Shares were sold in the market on 8 July 2024 at a weighted average price of 97.789 pence per Share.

The awards which automatically vested were granted under the DBP on 6 July 2022 (the shares released being the second half of the portion of the FY22 bonus which was deferred and share settled).

The vesting of these awards and the sale of shares to fund withholdings creates a change in the interests of each of them in the ordinary shares of 44152/175p of the Company ("Shares"):

Name of Director/PDMR

Role

Number of Shares subject to the Awards vesting

Number of Shares sold in the market

Number of Shares retained by the PDMR

Clive Vacher

CEO

67,315

31,751

35,564

Ruth Euling

MD, Currency

31,844

15,021

16,823

 

Following these transactions, the holdings of each of the PDMRs of the Company's Shares are as follows:

 

Name of Director/PDMR

Role

Number of Shares held by the PDMR

Clive Vacher

CEO

338,687

Ruth Euling

MD, Currency

102,225

 

 

 

The relevant information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation as retained in UK law.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Clive Vacher

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(a) Vesting of a conditional award in respect of a total of 67,315 Shares under the rules of the De La Rue Deferred Bonus Plan.

(b) Sale of Shares to fund income tax and national insurance withholdings and the associated dealing costs

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

(a) £0.00

(b) £0.97789

 

(a) 67,315

(b) 31,751

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

(a) 8 July 2024

(b) 8 July 2024

f)

 

Place of the transaction

 

(a) Outside a trading venue

(b) London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ruth Euling

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/MD, Currency

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(a) Vesting of a conditional award in respect of a total of 31,844 Shares under the rules of the De La Rue Deferred Bonus Plan.

(b) Sale of Shares to fund income tax and national insurance withholdings and the associated dealing costs

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

(a) £0.00

(b) £0.97789

 

(a) 31,844

(b) 15,021

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

(a) 8 July 2024

(b) 8 July 2024

f)

 

Place of the transaction

 

(a) Outside a trading venue

(b) London Stock Exchange

 

 

Jon Messent, Company Secretary

Contact Number: 01256 605212

9 July 2024

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASXNEAFLEFA
Date   Source Headline
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company
27th Jun 20231:57 pmRNSHolding(s) in Company
27th Jun 20231:54 pmRNSHolding(s) in Company
26th Jun 20237:00 amRNSDirectorate Change
22nd Jun 20234:43 pmRNSHolding(s) in Company
21st Jun 20233:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSDirectorate Change
12th Jun 20237:00 amRNSDirectorate Change
1st Jun 202310:36 amRNSTotal Voting Rights
23rd May 20234:33 pmRNSHolding(s) in Company
18th May 20237:00 amRNSAppointment of Chairman
9th May 20237:00 amRNSNotice of Results
2nd May 20237:00 amRNSFurther re recruitment of Chairman
18th Apr 20232:52 pmRNSWithdrawal of General Meeting requisition
14th Apr 20234:19 pmRNSResignation of Chairman and accelerated search
12th Apr 20237:00 amRNSTrading update
6th Apr 20237:00 amRNSFurther re appointment of CFO
3rd Apr 202311:41 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSNotice of GM
30th Mar 202312:24 pmRNSHolding(s) in Company
24th Mar 202310:46 amRNSHolding(s) in Company
23rd Mar 202310:38 amRNSHolding(s) in Company
17th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20232:00 pmRNSHolding(s) in Company
22nd Feb 20231:03 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSDirectorate Change
20th Jan 20237:00 amRNSStatement re Kenya and India
6th Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 202312:14 pmRNSBlock listing Interim Review
2nd Dec 20224:42 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.